TY - JOUR
T1 - HIV outbreaks among people who inject drugs in Europe, North America, and Israel
AU - Des Jarlais, Don C.
AU - Sypsa, Vana
AU - Feelemyer, Jonathan
AU - Abagiu, Adrian O.
AU - Arendt, Vic
AU - Broz, Dita
AU - Chemtob, Daniel
AU - Seguin-Devaux, Carole
AU - Duwve, Joan M.
AU - Fitzgerald, Margaret
AU - Goldberg, David J.
AU - Hatzakis, Angelos
AU - Jipa, Raluca E.
AU - Katchman, Eugene
AU - Keenan, Eamon
AU - Khan, Ibrahim
AU - Konrad, Stephanie
AU - McAuley, Andrew
AU - Skinner, Stuart
AU - Wiessing, Lucas
N1 - Funding Information:
We are grateful to the US National Institute on Drug Abuse (R01DA003574) for funding this work. The funding agency had no role in the design, conduct, data analysis, or report preparation of the study.
Funding Information:
SS reports grants and personal fees from Merck Canada, ViiV Healthcare, and Gilead Sciences, and grants from AbbVie, outside the submitted work. VS reports grants, personal fees, and non-financial support from Gilead Sciences and AbbVie, outside the submitted work. AH reports grants from AbbVie, Gilead Sciences, and MSD, outside the submitted work. JMD reports grants from AbbVie and Gilead Sciences, outside the submitted work. All other authors declare no competing interests.
Publisher Copyright:
© 2020 Elsevier Ltd
PY - 2020/6
Y1 - 2020/6
N2 - During 2011–16, HIV outbreaks occurred among people who inject drugs (PWID) in Canada (southeastern Saskatchewan), Greece (Athens), Ireland (Dublin), Israel (Tel Aviv), Luxembourg, Romania (Bucharest), Scotland (Glasgow), and USA (Scott County, Indiana). Factors common to many of these outbreaks included community economic problems, homelessness, and changes in drug injection patterns. The outbreaks differed in size (from under 100 to over 1000 newly reported HIV cases among PWID) and in the extent to which combined prevention had been implemented before, during, and after the outbreaks. Countries need to ensure high coverage of HIV prevention services and coverage higher than the current UNAIDS recommendation might be needed in areas in which short acting drugs are injected. In addition, monitoring of PWID with special attention for changing drug use patterns, risk behaviours, and susceptible subgroups (eg, PWID experiencing homelessness) needs to be in place to prevent or rapidly detect and contain new HIV outbreaks.
AB - During 2011–16, HIV outbreaks occurred among people who inject drugs (PWID) in Canada (southeastern Saskatchewan), Greece (Athens), Ireland (Dublin), Israel (Tel Aviv), Luxembourg, Romania (Bucharest), Scotland (Glasgow), and USA (Scott County, Indiana). Factors common to many of these outbreaks included community economic problems, homelessness, and changes in drug injection patterns. The outbreaks differed in size (from under 100 to over 1000 newly reported HIV cases among PWID) and in the extent to which combined prevention had been implemented before, during, and after the outbreaks. Countries need to ensure high coverage of HIV prevention services and coverage higher than the current UNAIDS recommendation might be needed in areas in which short acting drugs are injected. In addition, monitoring of PWID with special attention for changing drug use patterns, risk behaviours, and susceptible subgroups (eg, PWID experiencing homelessness) needs to be in place to prevent or rapidly detect and contain new HIV outbreaks.
UR - http://www.scopus.com/inward/record.url?scp=85085761355&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85085761355&partnerID=8YFLogxK
U2 - 10.1016/S2352-3018(20)30082-5
DO - 10.1016/S2352-3018(20)30082-5
M3 - Review article
C2 - 32504576
AN - SCOPUS:85085761355
VL - 7
SP - e434-e442
JO - The Lancet HIV
JF - The Lancet HIV
SN - 2352-3018
IS - 6
ER -